PROCEPT BioRobotics Corporation (PRCT)

$37.84

-0.49 (-1.28%)
Rating:
Recommendation:
-
Symbol PRCT
Price $37.84
Beta 0.000
Volume Avg. 0.37M
Market Cap 1.687B
Shares () -
52 Week Range 15.38-52.4
1y Target Est -
DCF Unlevered PRCT DCF ->
DCF Levered PRCT LDCF ->
ROE -32.32% Strong Sell
ROA -27.08% Sell
Operating Margin -
Debt / Equity 29.99% Neutral
P/E -
P/B 7.01 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest PRCT news


Healthcare
Medical Devices
NASDAQ Global Market

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.